Risk of Developing Severe Alimentary-Constitutional Obesity and Metabolic Disorders: Interventional Comparative Study

Background. The relevance of alimentary-constitutional obesity, especially its severe forms, is associated with a number of metabolic disorders, subsequently leading to serious chronic noncommunicable diseases.

Objective. To identify factors that increase the risk of severe alimentary-constitutional obesity and metabolic disorders.

Methods. A follow-up group of 426 patients aged 18 to 65 years was formed among those seeking help from an endocrinologist for overweight or obesity. The diagnosis of alimentary-constitutional obesity was confirmed at the initial examination in the outpatient clinic setting. Depending on the severity of obesity and the type of fat deposition according to anthropometric data (body mass index, waist circumference), the study participants were ratified into two study groups. The research was conducted between 2010 and 2017 in outpatient settings and was based on a cross-sectional comparative study. In order to assess the risk of severe obesity and factors associated with it, the authors studied medical history data, results of physical examination, including blood pressure level, laboratory examination with analysis of carbohydrate, fat metabolism and liver function, assessed eating behaviour, and performed diagnosis of anxiety-depressive disorder. Statistical analysis of the results was carried out using Statistica 10 (StatSoft, USA).

Results. Women are more likely to see an endocrinologist with less severe obesity than men. Severe obesity risk is higher in middle-aged and elderly people, as well as in hereditary tainted patients and those having a history of obesity for more than 10 years. Severe obesity itself is a significant risk for metabolic events, with a 4-fold higher risk of hyperglycaemia and hypercholesterolaemia (due to very low density lipoproteins) and a 5-fold higher risk of hyperinsulinaemia and insulin resistance.

Conclusion. Analysis of severe obesity risks has shown that earlier personal commitment to a healthy lifestyle is essential for weight loss and subsequent improvement of metabolic parameters, particularly in men and those aged 45 years or older.

1. Gerbali O.Yu., Kostyrnoy A.V. Prevalence simultation of pathology of patients wits cholelithiasis and the metabolic syndrome. Kuban Scientifi c Medical Bulletin. 2014; 5: 26–29 (In Russ.). DOI: 10.25207/1608-6228-2014-5-26-29

2. vanova A.Yu., Dolgalev I.V. Impact of overweight and obesity on mortality (according to the results of a 27-year prospective study). Profi lakticheskaya Meditsina. 2017; 20(3): 34–39 (In Russ.). DOI: 10.17116/profmed201720334-39

3. Seidell J.C., Halberstadt J. The global burden of obesity and the challenges of prevention. Ann. Nutr. Metab. 2015; 66 Suppl 2: 7–12. DOI: 10.1159/000375143

4. Collins K.H., Herzog W., MacDonald G.Z., Reimer R.A., Rios J.L., Smith I.C., Zernicke R.F., Hart D.A. Obesity, Metabolic Syndrome, and Musculoskeletal Disease: Common Infl ammatory Pathways Suggest a Central Role for Loss of Muscle Integrity. Front. Physiol. 2018; 9: 112. DOI: 10.3389/fphys.2018.00112

5. Gortmaker S.L., Swinburn B.A., Levy D., Carter R., Mabry P.L., Finegood D.T., Huang T., Marsh T., Moodie M.L. Changing the future of obesity: science, policy, and action. Lancet. 2011; 378(9793): 838–847. DOI: 10.1016/S0140-6736(11)60815-5

6. Martins A.D., Majzoub A., Agawal A. Metabolic Syndrome and Male Fertility. World. J. Mens. Health. 2019; 37(2): 113–127. DOI: 10.5534/wjmh.180055

7. Mansur R.B., Brietzke E., McIntyre R.S. Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders. Neurosci. Biobehav. Rev. 2015; 52: 89–104. DOI: 10.1016/j.neubiorev.2014.12.017

8. Qiu W., Cai X., Zheng C., Qiu S., Ke H., Huang Y. Update on the Relationship Between Depression and Neuroendocrine Metabolism. Front. Neurosci. 2021; 15: 728810. DOI: 10.3389/fnins.2021.728810

9. Tinahones F.J., Garrido-Sánchez L., Murri M., García-Fuentes E., Cardona F. Particular characteristics of the metabolic syndrome in patients with morbid obesity. Endocrinol. Nutr. 2013; 60(3): 127–135. DOI: 10.1016/j.endonu.2012.09.007

10. Kastueva N.D., Tsidaeva T.D., Belikova Z.F., Maysuradze L.V. Pathogenetic aspects of metabolic syndrome in women of reproductive age (a literature review). Kuban Scientifi c Medical Bulletin. 2019; 26(2): 162–172 (In Russ.). DOI: 10.25207/1608-6228-2019-26-2-162-172

11. Nwankwo M., Okamkpa C.J., Danborno B. Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast Nigeria. Diabetes. Metab. Syndr. 2022; 16(12): 102665. DOI: 10.1016/j.dsx.2022.102665. Epub 2022 Nov 16. PMID: 36417829.

12. Ceolin J., Engroff P., Mattiello R., Schwanke C.H.A. Performance of Anthropometric Indicators in the Prediction of Metabolic Syndrome in the Elderly. Metab. Syndr. Relat. Disord. 2019; 17(4): 232–239. DOI: 10.1089/met.2018.0113

13. Bedenko A.S., Antonenko L.M. Metabolic disorders in patients with vestibular migraine. Epilepsy and paroxysmal conditions. 2021; 13(4): 359–366 (In Russ.). DOI: 10.17749/2077-8333/epi.par.con.2021.094

14. Read J.R., Sharpe L., Modini M., Dear B.F. Multimorbidity and depression: A systematic review and meta-analysis. J. Affect. Disord. 2017; 221: 36–46. DOI: 10.1016/j.jad.2017.06.009

15. Mason T.B., Pacanowski C.R., Lavender J.M., Crosby R.D., Wonderlich S.A., Engel S.G., Mitchell J.E., Crow S.J., Peterson C.B. Evaluating the Ecological Validity of the Dutch Eating Behavior Questionnaire Among Obese Adults Using Ecological Momentary Assessment. Assessment. 2019; 26(5): 907–914. DOI: 10.1177/1073191117719508

16. Razina A.O., Runenko S.D., Achkasov E.E. Obesity: current global and russian trends. Annals of the Russian Academy of Medical Sciences. 2016; 71(2): 154– 159 (In Russ.). DOI: 10.15690/vramn655

17. Singh R.K., Kumar P, Mahalingam K. Molecular genetics of human obesity: A comprehensive review. C. R. Biol. 2017; 340(2): 87–108. DOI: 10.1016/j.crvi.2016.11.007

18. Borodina S.V., Gapparova K.M., Zainudiniv Z.M., Grigorian O.N. Genetic predictors of obesity development. Obesity and Metabolism. 2016; 13(2): 7–13 (In Russ.). DOI: 10.14341/omet201627-13

19. Ruyatkina L.A., Ruyatkin D.S. Obesity: The Crossroads of Opinion, Knowledge, and Opportunity. Medical Council. 2020; 7: 108–120 (In Russ.). DOI: 10.21518/2079-701X-2020-7-108-120

20. Kytikova O.Yu., Antonyuk M.V., Kantur T.A., Novgorodtseva T.P., Denisenko Y.K. Prevalence and biomarkers in metabolic syndrome. Obesity and metabolism. 2021; 18(3): 302–312 (In Russ.). DOI: 10.14341/omet12704

21. Jantaratnotai N., Mosikanon K., Lee Y., McIntyre R.S. The interface of depression and obesity. Obes. Res. Clin. Pract. 2017; 11(1): 1–10. DOI: 10.1016/j.orcp.2016.07.003

22. Sutton C.A., L’Insalata A.M., Fazzino T.L. Reward sensitivity, eating behavior, and obesity-related outcomes: A systematic review. Physiol. Behav. 2022; 252: 113843. DOI: 10.1016/j.physbeh.2022.113843

23. Godet A., Fortier A., Bannier E., Coquery N., Val-Laillet D. Interactions between emotions and eating behaviors: Main issues, neuroimaging contributions, and innovative preventive or corrective strategies. Rev. Endocr. Metab. Disord. 2022; 23(4): 807–831. DOI: 10.1007/s11154-021-09700-x

24. Yurenev G..L., Mironova E.M., Sirota N.A., Yureneva-Tkhorzhevskaya T.V. Features of psychoemotional status and eating disorders in patients with gastroesophageal refl ux disease and obesity. Consilium Medicum. 2021; 23(5): 412–416 (In Russ.). DOI: 10.26442/20751753.2021.5.200932